Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 1
1976 1
1977 2
1980 1
1981 2
1984 1
1985 3
1986 5
1987 3
1988 5
1989 3
1990 1
1992 1
1993 1
1994 7
1995 3
1996 4
1997 3
1998 4
1999 4
2000 2
2001 8
2002 7
2003 6
2004 9
2005 6
2006 6
2007 4
2008 12
2009 12
2010 13
2011 20
2012 17
2013 20
2014 22
2015 18
2016 13
2017 15
2018 18
2019 29
2020 28
2021 29
2022 20
2023 24
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
PD Med Collaborative Group; Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. PD Med Collaborative Group, et al. Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Lancet. 2014. PMID: 24928805 Clinical Trial.
We aimed to establish which of these three classes of drug, as initial treatment, provides the most effective long-term control of symptoms and best quality of life for people with early Parkinson's disease. ...
We aimed to establish which of these three classes of drug, as initial treatment, provides the most effective long-term control of sy …
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease.
Fujiwara N, Kubota N, Crouchet E, Koneru B, Marquez CA, Jajoriya AK, Panda G, Qian T, Zhu S, Goossens N, Wang X, Liang S, Zhong Z, Lewis S, Taouli B, Schwartz ME, Fiel MI, Singal AG, Marrero JA, Fobar AJ, Parikh ND, Raman I, Li QZ, Taguri M, Ono A, Aikata H, Nakahara T, Nakagawa H, Matsushita Y, Tateishi R, Koike K, Kobayashi M, Higashi T, Nakagawa S, Yamashita YI, Beppu T, Baba H, Kumada H, Chayama K, Baumert TF, Hoshida Y. Fujiwara N, et al. Among authors: lewis s. Sci Transl Med. 2022 Jun 22;14(650):eabo4474. doi: 10.1126/scitranslmed.abo4474. Epub 2022 Jun 22. Sci Transl Med. 2022. PMID: 35731891 Free PMC article.
In cohorts of 409 patients with NAFLD from multiple global regions, we defined and validated hepatic transcriptome and serum secretome signatures predictive of long-term HCC risk in patients with NAFLD. A 133-gene signature, prognostic liver signature (PLS)-NAFLD, predicte …
In cohorts of 409 patients with NAFLD from multiple global regions, we defined and validated hepatic transcriptome and serum secretome signa …
The Stanford Hall consensus statement for post-COVID-19 rehabilitation.
Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. Barker-Davies RM, et al. Among authors: lewis s. Br J Sports Med. 2020 Aug;54(16):949-959. doi: 10.1136/bjsports-2020-102596. Epub 2020 May 31. Br J Sports Med. 2020. PMID: 32475821 Free PMC article.
Although COVID-19 predominantly affects the respiratory system, evidence indicates a multisystem disease which is frequently severe and often results in death. Long-term sequelae of COVID-19 are unknown, but evidence from previous CoV outbreaks demonstrates impaired pulmon …
Although COVID-19 predominantly affects the respiratory system, evidence indicates a multisystem disease which is frequently severe and ofte …
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. ...
BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibit …
Long-term thermal sensitivity of Earth's tropical forests.
Sullivan MJP, Lewis SL, Affum-Baffoe K, Castilho C, Costa F, Sanchez AC, Ewango CEN, Hubau W, Marimon B, Monteagudo-Mendoza A, Qie L, Sonké B, Martinez RV, Baker TR, Brienen RJW, Feldpausch TR, Galbraith D, Gloor M, Malhi Y, Aiba SI, Alexiades MN, Almeida EC, de Oliveira EA, Dávila EÁ, Loayza PA, Andrade A, Vieira SA, Aragão LEOC, Araujo-Murakami A, Arets EJMM, Arroyo L, Ashton P, Aymard C G, Baccaro FB, Banin LF, Baraloto C, Camargo PB, Barlow J, Barroso J, Bastin JF, Batterman SA, Beeckman H, Begne SK, Bennett AC, Berenguer E, Berry N, Blanc L, Boeckx P, Bogaert J, Bonal D, Bongers F, Bradford M, Brearley FQ, Brncic T, Brown F, Burban B, Camargo JL, Castro W, Céron C, Ribeiro SC, Moscoso VC, Chave J, Chezeaux E, Clark CJ, de Souza FC, Collins M, Comiskey JA, Valverde FC, Medina MC, da Costa L, Dančák M, Dargie GC, Davies S, Cardozo ND, de Haulleville T, de Medeiros MB, Del Aguila Pasquel J, Derroire G, Di Fiore A, Doucet JL, Dourdain A, Droissart V, Duque LF, Ekoungoulou R, Elias F, Erwin T, Esquivel-Muelbert A, Fauset S, Ferreira J, Llampazo GF, Foli E, Ford A, Gilpin M, Hall JS, Hamer KC, Hamilton AC, Harris DJ, Hart TB, Hédl R, Herault B, Herrera R, Higuchi N, Hladik A… See abstract for full author list ➔ Sullivan MJP, et al. Among authors: lewis sl. Science. 2020 May 22;368(6493):869-874. doi: 10.1126/science.aaw7578. Epub 2020 May 21. Science. 2020. PMID: 32439789 Free article.
The sensitivity of tropical forest carbon to climate is a key uncertainty in predicting global climate change. Although short-term drying and warming are known to affect forests, it is unknown if such effects translate into long-term responses. ...Our results nevert …
The sensitivity of tropical forest carbon to climate is a key uncertainty in predicting global climate change. Although short-term dr …
Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study.
Jones HJ, Borges MC, Carnegie R, Mongan D, Rogers PJ, Lewis SJ, Thompson AD, Zammit S. Jones HJ, et al. Among authors: lewis sj. Lancet Psychiatry. 2021 Dec;8(12):1062-1070. doi: 10.1016/S2215-0366(21)00286-8. Epub 2021 Nov 1. Lancet Psychiatry. 2021. PMID: 34735824
FADS gene cluster and ELOVL2 gene causal effects on schizophrenia were calculated by dividing the single nucleotide polymorphism (SNP)-schizophrenia effect estimate by the SNP-fatty acid effect estimate with standard errors derived using the first term from a delta method …
FADS gene cluster and ELOVL2 gene causal effects on schizophrenia were calculated by dividing the single nucleotide polymorphism (SNP)-schiz …
Public health and international drug policy.
Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, Cepeda J, Comfort M, Goosby E, Goulão J, Hart C, Kerr T, Lajous AM, Lewis S, Martin N, Mejía D, Camacho A, Mathieson D, Obot I, Ogunrombi A, Sherman S, Stone J, Vallath N, Vickerman P, Zábranský T, Beyrer C. Csete J, et al. Among authors: lewis s. Lancet. 2016 Apr 2;387(10026):1427-1480. doi: 10.1016/S0140-6736(16)00619-X. Epub 2016 Mar 24. Lancet. 2016. PMID: 27021149 Free PMC article. Review.
While regulated legal drug markets are not politically possible in the short term in some places, the harms of criminal markets and other consequences of prohibition catalogued in this report are likely to lead more countries (and more US states) to move gradually in that …
While regulated legal drug markets are not politically possible in the short term in some places, the harms of criminal markets and o …
Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Benfield P, Heel RC, Lewis SP. Benfield P, et al. Among authors: lewis sp. Drugs. 1986 Dec;32(6):481-508. doi: 10.2165/00003495-198632060-00002. Drugs. 1986. PMID: 2878798 Review.
Both the parent compound and metabolite possess elimination half-lives of several days facilitating the maintenance of steady-state plasma concentrations during long term treatment. Fluoxetine has overall therapeutic efficacy comparable with imipramine, amitriptyline and d …
Both the parent compound and metabolite possess elimination half-lives of several days facilitating the maintenance of steady-state plasma c …
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
Writing Committee for the REMAP-CAP Investigators; Higgins AM, Berry LR, Lorenzi E, Murthy S, McQuilten Z, Mouncey PR, Al-Beidh F, Annane D, Arabi YM, Beane A, van Bentum-Puijk W, Bhimani Z, Bonten MJM, Bradbury CA, Brunkhorst FM, Burrell A, Buzgau A, Buxton M, Charles WN, Cove M, Detry MA, Estcourt LJ, Fagbodun EO, Fitzgerald M, Girard TD, Goligher EC, Goossens H, Haniffa R, Hills T, Horvat CM, Huang DT, Ichihara N, Lamontagne F, Marshall JC, McAuley DF, McGlothlin A, McGuinness SP, McVerry BJ, Neal MD, Nichol AD, Parke RL, Parker JC, Parry-Billings K, Peters SEC, Reyes LF, Rowan KM, Saito H, Santos MS, Saunders CT, Serpa-Neto A, Seymour CW, Shankar-Hari M, Stronach LM, Turgeon AF, Turner AM, van de Veerdonk FL, Zarychanski R, Green C, Lewis RJ, Angus DC, McArthur CJ, Berry S, Derde LPG, Gordon AC, Webb SA, Lawler PR. Writing Committee for the REMAP-CAP Investigators, et al. JAMA. 2023 Jan 3;329(1):39-51. doi: 10.1001/jama.2022.23257. JAMA. 2023. PMID: 36525245 Free PMC article.
IMPORTANCE: The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown. OBJECTIVE: To determine the effect of multiple interventions for critically ill adults with COVID-19 on longer-term outcomes. DESIGN, SETTING, AN …
IMPORTANCE: The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown. OBJECTIVE: T …
383 results